Cutler Group LP Aclaris Therapeutics, Inc. Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$13.38 - $18.8 $8,028 - $11,280	-600 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$17.08 - $29.6 $39,283 - $68,080	-2,300 Reduced 79.31%	600 $10,000
Q1 2021 Apr 26, 2021	SELL	$5.86 - $27.73 $4,102 - $19,411	-700 Reduced 19.44%	2,900 $73,000
Q3 2020 Oct 27, 2020	BUY	$1.5 - $2.71 $300 - $542	200 Added 5.88%	3,600 $9,000
Q4 2019 Feb 06, 2020	SELL	$1.02 - $1.97 $3,162 - $6,107	-3,100 Reduced 47.69%	3,400 $6,000
Q3 2019 Oct 28, 2019	SELL	$0.79 - $2.47 $2,291 - $7,163	-2,900 Reduced 30.85%	6,500 $7,000
Q2 2019 Aug 09, 2019	BUY	$2.13 - $7.06 $19,383 - $64,246	9,100 Added 3033.33%	9,400 $20,000
Q1 2019 May 10, 2019	SELL	$5.63 - $7.84 $563 - $784	-100 Reduced 25.0%	300 $1,000
Q4 2018 Feb 05, 2019	BUY	$6.3 - $15.4 $2,520 - $6,160	400 New	400 $2,000
Q3 2018 Nov 07, 2018	SELL	$14.38 - $20.89 $2,876 - $4,178	-200 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$16.46 - $20.33 $4,938 - $6,098	-300 Reduced 60.0%	200 $3,000
Q1 2018 May 11, 2018	SELL	$17.08 - $25.64 $5,123 - $7,692	-300 Reduced 37.5%	500 $8,000
Q4 2017 Jan 17, 2018	BUY	$21.47 - $27.8 $15,029 - $19,460	700 Added 700.0%	800 $19,000
Q3 2017 Oct 17, 2017	BUY	$23.02 - $28.8 $2,302 - $2,880	100	100 $2,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.